Inflammatory Profile in Cystinosis Metabolic Bone Disease
Author Information
Author(s): Alioli Candide, Greco Marcella, Méaux Marie-Noëlle, Harambat Jérome, Topaloglu Rezan, Nobili François, Bertholet-Thomas Aurélia, Rousset-Rouviere Caroline, Portefaix Aurélie, Dumortier Claire, Emma Francesco, Machuca-Gayet Irma, Bacchetta Justine
Primary Institution: Hospices Civils de Lyon
Hypothesis
What is the pro-inflammatory profile of osteoclastic lineage in cystinotic patients?
Conclusion
Cystinotic patients exhibit an inflammatory profile in their blood cells and osteoclasts, which may contribute to increased bone disease.
Supporting Evidence
- Cystinosis metabolic bone disease (CMBD) leads to bone pain and fractures in affected patients.
- Blocking IL-1β signaling may improve muscle wasting in cystinosis.
- Significant increases in IL-6, IL-8, CXCR3, and CCL2/MCP-1 were found in PBMCs from cystinotic patients.
Takeaway
Kids with a rare disease called cystinosis have inflammation in their blood cells that can hurt their bones, and doctors are looking for ways to help them feel better.
Methodology
Blood samples were taken from 14 cystinotic patients and 10 healthy controls to analyze inflammatory markers using RT-qPCR.
Potential Biases
Potential bias due to the selection of healthy controls from a different study.
Limitations
The healthy controls were matched on age and gender but were initially used for a study on another disease, which may introduce bias.
Participant Demographics
14 cystinotic patients with a median age of 8.4 years and 10 healthy pediatric controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website